Vascular liver disorders (I) : diagnosis, treatment and prognosis of Budd-Chiari syndromeHOEKSTRA, J; JANSSEN, H. L. A.Netherlands journal of medicine. 2008, Vol 66, Num 8, pp 334-339, issn 0300-2977, 6 p.Article

Vascular liver disorders (II): portal vein thrombosisHOEKSTRA, J; JANSSEN, H. L. A.Netherlands journal of medicine. 2009, Vol 67, Num 2, pp 46-53, issn 0300-2977, 8 p.Article

Immunomodulatory therapy for chronic hepatitis B virus infectionSPRENGERS, D; JANSSEN, H. L. A.Fundamental & clinical pharmacology. 2005, Vol 19, Num 1, pp 17-26, issn 0767-3981, 10 p.Article

Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCVBERGMANN, J. F; DE BRUIJNE, J; RAHIMY, M et al.Alimentary pharmacology & therapeutics. 2011, Vol 34, Num 4, pp 443-453, issn 0269-2813, 11 p.Article

Treatment of chronic hepatitis C virus infection : Dutch national guidelinesDE BRUIJNE, J; BUSTER, E. H. C. J; REESINK, H. W et al.Netherlands journal of medicine. 2008, Vol 66, Num 7, pp 311-322, issn 0300-2977, 12 p.Article

Interferon-alpha therapy for chronic hepatitis B : Early response related to pre-treatment changes in viral replicationHEIJTINK, R. A; JANSSEN, H. L. A; HOP, W. C. J et al.Journal of medical virology. 2001, Vol 63, Num 3, pp 217-219, issn 0146-6615Article

Fatal hepatic decompensation associated with inteferon alfaJANSSEN, H. L. A; BROUWER, J. T; NEVENS, F et al.BMJ. British medical journal (International ed.). 1993, Vol 306, Num 6870, pp 107-108, issn 0959-8146Article

Pregnancy in women with portal vein thrombosis: Results of a multicentric European study on maternal and fetal management and outcomeHOEKSTRA, J; SEIJO, S; THABUT, D et al.Journal of hepatology. 2012, Vol 57, Num 6, pp 1214-1219, issn 0168-8278, 6 p.Article

Ascites in patients with noncirrhotic nonmalignant extrahepatic portal vein thrombosisSPAANDER, M. C. W; VAN BUUREN, H. R; HANSEN, B. E et al.Alimentary pharmacology & therapeutics. 2010, Vol 32, Num 4, pp 529-534, issn 0269-2813, 6 p.Article

Human hepatic lymph nodes contain normal numbers of mature myeloid dendritic cells but few plasmacytoid dendritic cellsTANIS, W; MANCHAM, S; SCHALM, S. W et al.Clinical immunology (Orlando, Fla. Print). 2004, Vol 110, Num 1, pp 81-88, issn 1521-6616, 8 p.Article

Durability of HBeAg seroconversion following antiviral therapy or chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferaseVAN NUNEN, A. B; HANSEN, B. E; SCHALM, S. W et al.Gut. 2003, Vol 52, Num 3, pp 420-424, issn 0017-5749, 5 p.Article

Fatal cerebral oedema associated with primary dengue infectionJANSSEN, H. L. A; BIENFAIT, H. P; JANSEN, C. L et al.The Journal of infection. 1998, Vol 36, Num 3, pp 344-346, issn 0163-4453Article

Quantitative measurement of HBeAg in chronic hepatitis B : a comparison between a radioimmunoassay, a fluorescence ELISA and a chemiluminescence ELISAHEITJINK, R. A; SNOBL, J; KRUINING, J et al.Journal of medical virology. 1995, Vol 47, Num 3, pp 245-250, issn 0146-6615Article

Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis BBROUWER, W. P; SONNEVELD, M. J; BOONSTRA, A et al.Alimentary pharmacology & therapeutics. 2014, Vol 40, Num 7, pp 811-818, issn 0269-2813, 8 p.Article

Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertensionSCHOUTEN, J. N. L; VAN DER ENDE, M. E; KOËTER, T et al.Alimentary pharmacology & therapeutics. 2012, Vol 36, Num 9, pp 875-885, issn 0269-2813, 11 p.Article

Treatment of chronic hepatitis B virus infection : Dutch national guidelinesBUSTER, E. H. C. J; VAN ERPECUM, K. J; SCHALM, S. W et al.Netherlands journal of medicine. 2008, Vol 66, Num 7, pp 292-306, issn 0300-2977, 15 p.Article

Review article : the management of non-cirrhotic non-malignant portal vein thrombosis and concurrent portal hypertension in adultsSPAANDER, V. M. C. W; VAN BUUREN, H. R; JANSSEN, H. L. A et al.Alimentary pharmacology & therapeutics. 2007, Vol 26, pp 203-209, issn 0269-2813, 7 p., SUP2Conference Paper

Extrahepatic portal vein thrombosis : aetiology and determinants of survivalJANSSEN, H. L. A; WIJNHOUD, A; ROSENDAAL, F. R et al.Gut. 2001, Vol 49, Num 5, pp 720-724, issn 0017-5749Article

Severe hepatitis and pure red cell aplasia in adult Still's disease: Good response to immunosuppressive therapyJANSSEN, H. L. A; VAN LAAR, J. M; VAN HOEK, B et al.Digestive diseases and sciences. 1999, Vol 44, Num 8, pp 1639-1642, issn 0163-2116Article

The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infectionBUSTER, E. H. C. J; BAAK, B. C; KOEK, G. H et al.Netherlands journal of medicine. 2012, Vol 70, Num 8, pp 381-385, issn 0300-2977, 5 p.Article

Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis CDE KNEGT, R. J; BEZEMER, G; VAN GOOL, A. R et al.Alimentary pharmacology & therapeutics. 2011, Vol 34, Num 11-12, pp 1306-1317, issn 0269-2813, 12 p.Article

Antiviral treatment for chronic hepatitis B virus infection : immune modulation or viral suppression?BUSTER, E. H. C. J; JANSSEN, H. L. A.Netherlands journal of medicine. 2006, Vol 64, Num 6, pp 175-185, issn 0300-2977, 11 p.Article

The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B : predictive factors for dose reduction and treatment discontinuationVAN ZONNEVELD, M; FLINK, H. J; DE MAN, R. A et al.Alimentary pharmacology & therapeutics. 2005, Vol 21, Num 9, pp 1163-1171, issn 0269-2813, 9 p.Article

Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during peg-interferon α-2b therapyFLINK, H. J; SPRENGERS, D; HANSEN, B. E et al.Gut. 2005, Vol 54, Num 11, pp 1604-1609, issn 0017-5749, 6 p.Article

Budd-Chiari syndrome : combination of genetic defects and the use of oral contraceptives leading to hypercoagulabilityMINNEMA, M. C; JANSSEN, H. L. A; NIERMEIJER, P et al.Journal of hepatology. 2000, Vol 33, Num 3, pp 509-512, issn 0168-8278Article